Nathan Weinstein

Nathan Weinstein

Managing Director - Head of Healthcare Equity Research
Mr. Weinstein began his career as an analyst intern at NGN Capital, a life sciences focused venture capital firm. Mr. Weinstein went on to work at Sidoti & Company and CL King & Associates. At those firms, Mr. Weinstein was involved with institutional equities, actively facilitating the distribution of equity research to investors including pension, mutual, and hedge-funds. Mr. Weinstein provided his clients with long/short idea flow, proprietary surveys, corporate access and conferences and led a successful business development effort that on boarded a significant number of new clients. Mr. Weinstein graduated from Binghamton University with degrees in Economics and English.

Companies Covered (By Industry)


CDTX Cidara Therapeutics, Inc.
CWBR CohBar, Inc.
ENTX Entera Bio Ltd.
GLSI Greenwich LifeSciences, Inc.
KIN Kindred Biosciences, Inc.
MDWD MediWound Ltd.
ORMP Oramed Pharmaceuticals, Inc.
MBII Marrone Bio Innovations, Inc.
KTRA Kintara Therapeutics, Inc.
SPRCY SciSparc Ltd.


VNRX VolitionRX Ltd.

Digital Therapeutics

DRIO DarioHealth Corp.